Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Neuro Block 8 > Alzheimers Disease And Dimentia > Flashcards

Alzheimers Disease And Dimentia Flashcards

1
Q

What is the clinical challenge of diagnosing mental status

A

Mental status changes and complaints often present without accompanying focal neurological signs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What can cognitive, emotional, motivational, behavioral signs stem from

A

Dysfunction from pathology; prefrontal cortex, thalamus, basal nuclei, limbic regions, hypothalamus, brainstem NT systems, etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Common mental status changes and complaints

A
  • difficulty concentrating
  • shortened attention span
  • memory deficits
  • confusion, impaired orientation to person, place, time
  • impaired alertness/consciousness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

A generic preliminary label meaning a diffuse brain pathology, a sense of localizing (focal) signs, various causes–infectious, metabolic, toxic, etc

A

Encephalopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

A confusional state-impaired orientation, alertness, concentration-with or without additional common complaints including emotional/physical agitation and hallucinations typically an cute, subacute scenario

A

Delirium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the key question to ask to narrow the DDX when there’s delirium

A

Acute, subacute, or chronic onset?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are some acute/subacute onset examples of delirium

A

Trauma, seizures, metabolic or toxic, infectious/inflammatory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Typically refers to a decline in cognitive and executive function, especially memory and behavioral control, with a chronic/insidious onset, usually progressive.

A

Dementia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What has Alzheimer’s previously been referred to

A

Senile dementia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

When does Alzheimer’s start

A

Older than 65

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Described as memory loss progressing to wide range of other cognitive impairments, then emotional/personality changes, and finally dementia

A

Alzheimer’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the neuropathology of Alzheimer’s

A

“Senile” or “neuritic” plaques and tangles, now known as amyloid plaques and neurofibrillary tangles
-extracellular deposits distributed widely in brain at end-stage of disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Neurotoxic-induce oxidative stress (free radical formation), disrupts neuronal membrane proteins functions, leads to excitotoxicity and neuronal cell death

A

Amyloid plaques-aggregates of beat-amyloid (AB) peptide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Symptomatic of neuronal cell death, degrades environment for live cells. Alzheimers

A

Tangles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the diagnosis of alzheimers

A

Post mortem neuropathology examination

  • amyloid plaques and neurofibrillary tangles being in hippocampus/entorhinal
  • then progression to other brain regions, affecting mroe functions
  • new neuroimaging techniques in development to assess neuropathology
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What does the cognitive decline in Alzheimer’s patients begin with

A

Memory impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the first stage of memory impairment in alzheimers

A

Memory impairment for recent events, then loss of remote memories

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Late stage dementia in alzheimers

A

Generalized impairment in cognition and behavioral regulation- remote retrograde amnesia, disorientation, gradual loss of independence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Function of amyloid precursor protein (APP) in healthy cells

A

Unknown in healthy cells, cleaved to yield neurotoxic amyloid proteins

20
Q

What is the normal APP enzymatically cleaved by

A

B-secretary

21
Q

After APP is enymatically cleaved by B-secret as ever, what happens

A

The y-secretase further cleaves the transmembrane fragment at various amino acid sites, from 38th to 43rd amino acids
-small percent of cleavage product is a 42 amino acid product AB42 or AB

22
Q

What is AB42

A

A small percentage of cleavage product from the y-secretase is this.
-it is neurotoxic although mechanisms still debated, possibly by disrupting function of many proteins, including cell membrane Na/K pump

23
Q

How is AB42 neurotoxic

A

Possibly by disruptin function of many proteins, including cell membrane Na/K pumps

24
Q

What does the original hypothesis say about AB42’s neurotoxicity

A

Must aggregate into plaques to become neurotoxic

25
Q

Recent research about AB42 neurotoxicity

A

Suggests that all forms of AB42 are neurotoxic, but that plaques may minimize damage by isolating it

26
Q

APP intracellular domain that acts as a transcription factor or regulator of transcription factors. Function remains debated but may act to promote apoptosis during brain development phase when excess neurogenesis happens and some neurons must undergo programmed cells death

A

AICD

27
Q

Role of APP in pre-synaptic terminal

A

Transmembrane receptor, but ligand and transduction effects are unknown
-transported down axon, animal model evidence for involvement in synsaoe strucure, function, and plasticity

28
Q

AB in pre-synaptic terminals

A
  • like APP, AB transported down the axon
  • AB intracelllar function and any secretory and extracellular roes is poorly understood
  • controversy is whether AB aggregation in amyloid plaques is more toxic or minimizes damage
29
Q

Accumulation of the cleaved AB protein

A

Accumulates in the EXTRACELLULAR matrix, these proteins bind together to form oligomers, which tend to have a toxic effect on the neurons disrupting their function

30
Q

Tau protein

A
  • hyper-phosphorylation of Tau protein de-stabilizes microtubules in dendrites and axons
  • simultaneously disrupts neuronal cytoskeleton, results in cell death, and debris from destroyed axons from extracellular neurofibrillary tangles
  • pathogenic cause for hyper-phosphorylation is still debated
31
Q

Earliest and highest density of histopathology in alzheimers

A

In hippocampus and parahippocampal gyrus (especially entorhinal cortex-sends projections to dentate gyrus)

32
Q

Is there a high density of neuropathology for alzheimers in the frontal lobe?

A

No

33
Q

Braak and Braak stages of alzheimers

A

Based on anatomical localization pattern of neurofibrillary tangles

34
Q

Cumulative effect of cellular level neuropathology in alzheimers

A

Gross cortical atrophy

35
Q

When do amyloid deposition and neurofibrillary tangles

A

Before symptoms start

-present in normal aging and in mild cognitive impairment (MCI)

36
Q

MCI

A

Statistically significant cognitive impairment but fails to meet life-disruptive criterion for alzheimers

37
Q

Mild cognitive impairment: search for alzheimers biomarkers during MCI

A
  • confirmation of alzheimers is still the post-mortem neuropathological analysis
  • current status of research on in vivo dx markers
  • PET/MRI of amyloid deposition, or AB load/burden
  • CSF sampling for AB and tau protein
  • peripheral marker candidates include inflammatory cytokines
38
Q

Mechanisms driving AB and tau protein formation in alzheimers

A

Not known.

39
Q

Current pharmacological approaches to alzheimers

A
  • acetylcholinesterase inhibitors-block acetylcholine metabolism (degradation) in synapse
  • memantine
40
Q

What does acetylcholinesterase inhibitors do

A
  • boosts cholinergic NT in sept-hippocampal system (medial septal nuclei to hippocampus)
  • boosts cholinergic NT in cholinergic projections to cerebral cortex from basal nucleus if meynert and sub innominata
  • enchanters attention/memory but does not stop neurodegeneration
41
Q

What does memantine

A

NMDA glutamate receptor antagonist

-block/reduce glutamate excitotoxicity

42
Q

Familial genetic factors for Alzheimer’s disease

A

Most AD cases are “sporadic” and not geneticall based or familial

43
Q

Protein subunits of y-secretase. Mutation thought to contribute to AB42 formation

A

Presinilins

44
Q

ApoE-Apolipoprotein E

A
  • major risk factor, 3-12 fold, depending on the polymorphism/isoform
  • in brain, produce by astrocytes
  • lipoprotein that helps cells internalize cholesterol and triglycerides
  • may have interactions with AB and presenilins
  • not specific to alzheimers
45
Q

Why is ApoE not specific to alzheimers

A

1/3 of AD cases do not have apoE mutations

-ApoE mutations are also seen in elderly without alzheimers

46
Q

Dementia with levy bodies

A

Dementia combined with Parkinson’s-like movement disorder

47
Q

Fronto-temporal dementia

A
  • originally called Pick’s disease
  • degeneration in frontal lobes and temporal lobes
  • primary signs are behavioral disinhibition, memory loss
  • degenerating neurons show tauopathy and intracellular inclusions

Neuro Block 8 (11 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions